Access cutting-edge esophageal squamous cell carcinoma treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this St Louis location
Preparing your pre-screening questions…
Access esophageal squamous cell carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related esophageal squamous cell carcinoma treatment provided free
Check if you qualify for this esophageal squamous cell carcinoma clinical trial in St Louis, MO
No-Cost Study Care
Local to St Louis
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
A multicenter, single-arm, first-in-human study to investigate the safety, pharmacokinetics, and preliminary antitumor activity of PLX-61639 in participants with locally advanced or metastatic, relapsed/refractory, SMARCA4-deficient solid tumors who are intolerant of or have failed available, approved therapies. The study will be conducted in 3 parts: dose escalation (Part 1), dose optimization (Part 2), and cohort expansion (Part 3). Each part of the study will consist of a Screening Phase lasting up to 28 days during which participants will be assessed for eligibility, a Treatment Phase beginning on Cycle 1 Day 1 and consisting of consecutive 28-day cycles, an End of Treatment Visit, and a Post-Treatment Follow-Up Phase. Participants will receive their assigned dose of PLX-61639 administered orally, once daily until progression/relapse, intolerance, death, or withdrawal from study treatment by the Investigator or participant.
Sponsor: Plexium, Inc.
Yes, this clinical trial (NCT07284186) has an active research site in St Louis, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for esophageal squamous cell carcinoma treatment options in St Louis, MO, this clinical trial (NCT07284186) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal squamous cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all esophageal squamous cell carcinoma clinical trials near you to find additional studies recruiting in your area.
See all esophageal cancer clinical trials recruiting in St Louis — not just this study.
Browse Esophageal Cancer Trials in St Louis →